Clinical Trials Directory

Trials / Completed

CompletedNCT04736875

Arteriovenous Fistula Maturation Evaluation Study. FAME Study

Study of the Hemodynamic and Clinical Maturation of the Native Arteriovenous Fistula for Hemodialysis

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Medifil AE · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Study of the features of hemodynamic and clinical maturation of the native arteriovenous fistula for hemodialysis.

Detailed description

This is a prospective, single-center, observational study, investigating the clinical and hemodynamic features of maturation of hemodialysis native arteriovenous fistula (AVF). Hemodynamic features under investigation are the diameter of the feeding brachial artery, volume of flow (VF) measured with transcutaneous Duplex ultrasound (DUS), resistivity index (RI), diameter and wall thickness of the efferent vein, measured at days 1, 2, 3, 4, 5, 6, 7, 14, 21, 30, 60 and 90 post creation. Clinical features of maturation are the time of first access successful cannulation and the performance of three consecutive adequate dialysis sessions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDoppler ultrasound studyTranscutaneous Doppler ultrasound (DUS) study was performed at the mid brachial artery to assess diameter, VF and RI, and at the mid segment of the efferent vein to assess the diameter and wall thickness.

Timeline

Start date
2019-02-01
Primary completion
2022-02-20
Completion
2022-02-20
First posted
2021-02-03
Last updated
2022-03-23

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04736875. Inclusion in this directory is not an endorsement.

Arteriovenous Fistula Maturation Evaluation Study. FAME Study (NCT04736875) · Clinical Trials Directory